Peter Lichtlen
2015
In 2015, Peter Lichtlen earned a total compensation of $1M as Chief Medical Officer at Sucampo Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $213,200 |
|---|---|
| Option Awards | $416,086 |
| Salary | $360,643 |
| Other | $60,069 |
| Total | $1,049,998 |
Lichtlen received $416.1K in option awards, accounting for 40% of the total pay in 2015.
Lichtlen also received $213.2K in non-equity incentive plan, $360.6K in salary and $60.1K in other compensation.
Rankings
In 2015, Peter Lichtlen's compensation ranked 7,716th out of 13,638 executives tracked by ExecPay. In other words, Lichtlen earned more than 43.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,716 out of 13,638 | 43rd |
Division Manufacturing | 2,923 out of 5,187 | 44th |
Major group Chemicals And Allied Products | 1,056 out of 1,857 | 43rd |
Industry group Drugs | 853 out of 1,531 | 44th |
Industry Pharmaceutical Preparations | 670 out of 1,179 | 43rd |
Source: SEC filing on April 18, 2016.
Lichtlen's colleagues
We found six more compensation records of executives who worked with Peter Lichtlen at Sucampo Pharmaceuticals in 2015.
2015
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2015
Andrew Smith
Sucampo Pharmaceuticals
Chief Financial Officer
2015
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2015
Thomas Knapp
Sucampo Pharmaceuticals
Chief Legal Officer
2015
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2015
Max Donley
Sucampo Pharmaceuticals